Document is current
Any future updates will be listed below
-
Authors
Abozeid, Dina O. https://orcid.org/0000-0002-9026-0652
Soliman, Fathy M.
Fawzy, Ghada A. https://orcid.org/0000-0002-3293-2836
Abdeltawab, Nourtan F. https://orcid.org/0000-0002-1290-2197
Al-mahallawi, Abdulaziz M. https://orcid.org/0000-0003-1694-1342
Emam, Khloud A. F. https://orcid.org/0000-0002-6184-3402
Marcus, Wagih H. https://orcid.org/0009-0008-6374-1101
Issa, Marwa Y. https://orcid.org/0000-0002-2181-7090
- License Information
-
More Information
Article History
Received: 25 January 2025
Accepted: 3 August 2025
First Online: 15 August 2025
Declarations
:
: The study was conducted in strict accordance with local, national, and international guidelines and legislation, with all necessary permits and licenses obtained from the relevant authorities to ensure ethical and legal compliance. The research ethics committee for experimental and clinical studies at the Faculty of Pharmacy, Cairo University, Cairo, Egypt approved all animal experiments with the protocol identification code MP (3031). The research procedures were carried out in compliance with the principles and recommendations of the Guidelines of the Care and Use of Laboratory Animals Association, A.V.M (Institute of Laboratory Animal Resources (US) 2011.
: All authors consent to the submission and publication of this manuscript in Future Journal of Pharmaceutical Sciences.
: There are no competing interests to declare.
